Impact of MHC class I diversity on immune control of immunodeficiency virus replication

Philip J R Goulder, David Watkins

Research output: Contribution to journalArticle

334 Citations (Scopus)

Abstract

The recent failure of the T-cell-based HIV vaccine trial led by Merck & Co., Inc. prompts the urgent need to refocus on the question of which T-cell responses are required to control HIV replication. The well-described association between the expression of particular MHC class I molecules and successful containment of HIV or, in the macaque model, SIV replication provide a valuable starting point from which to evaluate more precisely what might constitute effective CD8+ T-cell responses. Here, we review recent studies of T-cell-mediated control of HIV and SIV infection, and offer insight for the design of a successful T-cell-based HIV vaccine in the future.

Original languageEnglish
Pages (from-to)619-630
Number of pages12
JournalNature Reviews Immunology
Volume8
Issue number8
DOIs
StatePublished - Aug 1 2008
Externally publishedYes

Fingerprint

Virus Replication
T-Lymphocytes
AIDS Vaccines
HIV
Macaca
HIV Infections

ASJC Scopus subject areas

  • Immunology

Cite this

Impact of MHC class I diversity on immune control of immunodeficiency virus replication. / Goulder, Philip J R; Watkins, David.

In: Nature Reviews Immunology, Vol. 8, No. 8, 01.08.2008, p. 619-630.

Research output: Contribution to journalArticle

@article{400c529598f247088944e9a3302bd438,
title = "Impact of MHC class I diversity on immune control of immunodeficiency virus replication",
abstract = "The recent failure of the T-cell-based HIV vaccine trial led by Merck & Co., Inc. prompts the urgent need to refocus on the question of which T-cell responses are required to control HIV replication. The well-described association between the expression of particular MHC class I molecules and successful containment of HIV or, in the macaque model, SIV replication provide a valuable starting point from which to evaluate more precisely what might constitute effective CD8+ T-cell responses. Here, we review recent studies of T-cell-mediated control of HIV and SIV infection, and offer insight for the design of a successful T-cell-based HIV vaccine in the future.",
author = "Goulder, {Philip J R} and David Watkins",
year = "2008",
month = "8",
day = "1",
doi = "10.1038/nri2357",
language = "English",
volume = "8",
pages = "619--630",
journal = "Nature Reviews Immunology",
issn = "1474-1733",
publisher = "Nature Publishing Group",
number = "8",

}

TY - JOUR

T1 - Impact of MHC class I diversity on immune control of immunodeficiency virus replication

AU - Goulder, Philip J R

AU - Watkins, David

PY - 2008/8/1

Y1 - 2008/8/1

N2 - The recent failure of the T-cell-based HIV vaccine trial led by Merck & Co., Inc. prompts the urgent need to refocus on the question of which T-cell responses are required to control HIV replication. The well-described association between the expression of particular MHC class I molecules and successful containment of HIV or, in the macaque model, SIV replication provide a valuable starting point from which to evaluate more precisely what might constitute effective CD8+ T-cell responses. Here, we review recent studies of T-cell-mediated control of HIV and SIV infection, and offer insight for the design of a successful T-cell-based HIV vaccine in the future.

AB - The recent failure of the T-cell-based HIV vaccine trial led by Merck & Co., Inc. prompts the urgent need to refocus on the question of which T-cell responses are required to control HIV replication. The well-described association between the expression of particular MHC class I molecules and successful containment of HIV or, in the macaque model, SIV replication provide a valuable starting point from which to evaluate more precisely what might constitute effective CD8+ T-cell responses. Here, we review recent studies of T-cell-mediated control of HIV and SIV infection, and offer insight for the design of a successful T-cell-based HIV vaccine in the future.

UR - http://www.scopus.com/inward/record.url?scp=48749103238&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=48749103238&partnerID=8YFLogxK

U2 - 10.1038/nri2357

DO - 10.1038/nri2357

M3 - Article

C2 - 18617886

AN - SCOPUS:48749103238

VL - 8

SP - 619

EP - 630

JO - Nature Reviews Immunology

JF - Nature Reviews Immunology

SN - 1474-1733

IS - 8

ER -